Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Rhabdoid Tumor × Cisplatin × Clear all

Phase

Status

Completed 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 48 Squamous Cell Carcinoma of Head and Neck 25 Urinary Bladder Neoplasms 16 Head and Neck Neoplasms 16 Lung Neoplasms 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Oropharyngeal Neoplasms 10 Nasopharyngeal Carcinoma 10 Carcinoma 9 Uterine Cervical Neoplasms 7 Small Cell Lung Carcinoma 7 Pancreatic Neoplasms 7 Carcinoma, Transitional Cell 7 Carcinoma, Squamous Cell 7 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Colorectal Neoplasms 6 Cholangiocarcinoma 6 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Recurrence 5 Ovarian Neoplasms 5 Neoplasms 5 Neoplasm Metastasis 5 Mesothelioma, Malignant 5 Melanoma 5 Gallbladder Neoplasms 5 Biliary Tract Neoplasms 5 Stomach Neoplasms 4 Multiple Myeloma 4

Interventions

X-Rays 6 Phantoms, Imaging 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Biopsy 4 Cyclophosphamide 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Topotecan 2 Etoposide 2 tazemetostat 1 pembrolizumab 1 olaparib 1 atezolizumab 1 Vincristine 1 Vemurafenib 1 Tiragolumab 1 Temozolomide 1 Sirolimus 1 Radiotherapy 1 Pharmacogenomic Variants 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡